Quinton Fivelman

Chief Tech/Sci/R&D Officer at London Medical Laboratory Ltd.

Consumer Services

Health Services

Profile

Quinton Fivelman is currently the Chief Scientific Officer at London Medical Laboratory Ltd.
He completed his undergraduate degree at the University of Cape Town and his doctorate at the London School of Hygiene & Tropical Medicine.

Quinton Fivelman active positions

Companies	Position	Start
London Medical Laboratory Ltd. London Medical Laboratory Ltd. Medical/Nursing ServicesHealth Services London Medical Laboratory Ltd. operates as an independent clinical testing specialist and provides pathology diagnostics services. It offers tailor made clinical pathology diagnostic services to medical professionals, health care providers and patients. The firm also offers pathology testing solutions across disciplines including clinical biochemistry, immunology, haematology, sexual health screening and molecular biology. Its services include SARS-CoV-2 Swab PCR Swab Testing, SARS-CoV-2 Rapid Antigen Tests, SARS-CoV-2 IgG/IgM Antibody Testing, and Other Pathology Tests. The company was founded on November 4, 2016 and is headquartered in London, the United Kingdom.	Chief Tech/Sci/R&D Officer	-

All active positions of Quinton Fivelman

Training of Quinton Fivelman

London School of Hygiene & Tropical Medicine	Doctorate Degree
University of Cape Town	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Quinton Fivelman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
London Medical Laboratory Ltd. London Medical Laboratory Ltd. Medical/Nursing ServicesHealth Services London Medical Laboratory Ltd. operates as an independent clinical testing specialist and provides pathology diagnostics services. It offers tailor made clinical pathology diagnostic services to medical professionals, health care providers and patients. The firm also offers pathology testing solutions across disciplines including clinical biochemistry, immunology, haematology, sexual health screening and molecular biology. Its services include SARS-CoV-2 Swab PCR Swab Testing, SARS-CoV-2 Rapid Antigen Tests, SARS-CoV-2 IgG/IgM Antibody Testing, and Other Pathology Tests. The company was founded on November 4, 2016 and is headquartered in London, the United Kingdom.	Health Services